Testing a dietary oil for mild to moderate Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether a special form of a dietary fat called tricaprilin can help people with mild-to-moderate Alzheimer's disease. It may provide an alternative or add-on to current treatments to help with memory and thinking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of probable Alzheimer's disease.
- Your score on a standard memory test (MMSE) is between 14 and 24.
- You had an MRI brain scan within the last year that is consistent with Alzheimer's.
- You have a blood test result that supports the Alzheimer's diagnosis.
- If you take Alzheimer's medications, you've been on a stable dose for at least 6 weeks.
- You don't have other serious neurological, psychiatric, or digestive conditions that could explain your symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug for Alzheimer's called NTRX-07. It aims to see if it can slow memory decline for people with mild to moderate Alzheimer's.
This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.
This study tests a sequence of treatments to see if they can help people with Alzheimer's disease or mild cognitive impairment. It aims to slow down memory decline and improve daily function.
This trial tests an experimental drug, ARO-MAPT-SC, which may slow the progression of early Alzheimer's disease by targeting a protein involved in the disease. It is given as an injection under the skin and is being studied in healthy people and those with early Alzheimer's.
This study tests whether adding a treatment that improves blood vessel and insulin function can make the standard Alzheimer's medication work better for people with mild Alzheimer's or mild cognitive impairment.
This trial tests a drug called masitinib to see if it can help people with mild Alzheimer's disease. You'd get either the drug or a placebo, and doctors will check if your daily living skills and memory slow their decline.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.